Treatment of High Risk (HR) Smoldering Multiple Myeloma (SMM) with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed By Lenalidomide Maintenance (-R): A Phase 2 Clinical and Correlative Study
Resource Type
Abstract
Authors
Kazandjian, Dickran ; Hill, Elizabeth ; Morrison, Candis ; Dew, Alexander ; Korde, Neha ; Mailankody, Sham ; Manasanch, Elisabet E. ; Kwok, Mary L. ; Bhutani, Manisha ; Tageja, Nishant ; Zhang, Yong ; Carpenter, Ashley ; Epstein, Monica ; Emanuel, Michael ; Lu, Crystal ; Braylan, Raul C. ; Calvo, Katherine R. ; Choyke, Peter ; Dulau-Florea, Alina ; Mena, Esther ; Lindenberg, Liza ; Maric, Irina ; Patel, Nisha ; Stetler-Stevenson, Maryalice ; Wang, Hao-Wei ; Yuan, Constance M. ; Steinberg, Seth M. ; Figg, William D. ; Roschewski, Mark ; Landgren, Ola
Source
In Blood 5 November 2020 136 Supplement 1:43-45
Subject
Language
ISSN
0006-4971